ABCC1 p.Ser604Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 15260484
[PubMed]
Zhang DW et al: "Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1."
No.
Sentence
Comment
8
The third, S604A, selectively increased 17 -estradiol 17-( -D-glucuronide) (E217 G) transport.
X
ABCC1 p.Ser604Ala 15260484:8:11
status: NEW47 Ser604 was converted to Ala and Thr, and Asn590 was mutated to Ala, Gln, and Asp.
X
ABCC1 p.Ser604Ala 15260484:47:0
status: NEW60 Mutations S585A, N590A, N590Q, N590D, N597A, and S604A were generated using the QuikchangeSite-Directed Mutagenesis kit (STRATAGENE, La Jolla, CA).
X
ABCC1 p.Ser604Ala 15260484:60:49
status: NEW68 CGG TTT CCC-3'), N590D (5'-CT TTG GCC TTG TTC GAT ATC CTC CGG TTT CCC-3'), N597A (5'-CTC CGG TTT CCC CTG GCC ATT CTC CCC ATG GT-3'), and S604A (5'-CTC CCC ATG GTC ATC GCC AGC ATC GTG CAG GC-3') After confirming all mutations by DNA Thermo Sequenase Cy5.5 and Cy5.0 dye terminator cycle sequencing (Amersham Biosciences) according to the manufacturer`s instructions, DNA fragments containing the desired mutations were transferred into pCEBV7-MRP1.
X
ABCC1 p.Ser604Ala 15260484:68:137
status: NEW151 The levels of LTC4 uptake by vesicles prepared from HEK transfectants expressing either wild-type MRP1 or mutations Q580A, T581A, S585A, N597A, S604A, and S605A were proportional to the relative expression levels of the wild-type and mutant proteins.
X
ABCC1 p.Ser604Ala 15260484:151:144
status: NEW155 However, substitution of Ser604 with Ala (S604A) increased the transport efficiency by approximately 2-fold.
X
ABCC1 p.Ser604Ala 15260484:155:25
status: NEWX
ABCC1 p.Ser604Ala 15260484:155:42
status: NEW157 Thus, mutation S604A altered only the ability of MRP1 to transport the glucuronidated estrogen, whereas mutation N590A influenced the transport of both LTC4 and E217 G.
X
ABCC1 p.Ser604Ala 15260484:157:15
status: NEW168 To examine the influence of the N590A and S604A mutations more quantitatively, we compared their effect on the kinetic parameters of transport of both substrates (Figure 5).
X
ABCC1 p.Ser604Ala 15260484:168:42
status: NEW169 Mutation S604A had no effect on either the apparent Km or Vmax values for LTC4 uptake (Km 150 and 145 nM, and Vmax 89 and 84 pmol/ mg/min for wild-type MRP1 and mutation S604A, respectively) (Figure 5B and Table 1).
X
ABCC1 p.Ser604Ala 15260484:169:9
status: NEWX
ABCC1 p.Ser604Ala 15260484:169:170
status: NEW172 For E217 G transport, the Vmax value for mutation S604A was increased by 20-25% relative to wild-type MRP1 (197 pmol/mg/min for wild-type MRP1 vs 241 pmol/mg/min for the mutation), while the apparent Km was decreased ~2.5-fold (1.7 and 0.7 µM for wild-type MRP1 and mutation S604A, respectively) (Figure 5C and Table 1).
X
ABCC1 p.Ser604Ala 15260484:172:50
status: NEWX
ABCC1 p.Ser604Ala 15260484:172:56
status: NEWX
ABCC1 p.Ser604Ala 15260484:172:280
status: NEWX
ABCC1 p.Ser604Ala 15260484:172:286
status: NEW174 Thus, as observed with LTC4 as a substrate, mutation N590A decreased the Vmax/Km ratio for E217 G approximately 3-fold, whereas the S604A mutation increased the Vmax/Km ratio for this substrate approximately 3-fold.
X
ABCC1 p.Ser604Ala 15260484:174:132
status: NEWX
ABCC1 p.Ser604Ala 15260484:174:138
status: NEW175 These changes in transport efficiency were mediated predominantly by a decrease in apparent affinity for both LTC4 and E217 G as a result of the S604A mutation, while the N590A mutation increased the apparent Km and decreased the Vmax for E217 G.
X
ABCC1 p.Ser604Ala 15260484:175:145
status: NEWX
ABCC1 p.Ser604Ala 15260484:175:151
status: NEW203 Mutations Q580A, T581A, S585A, S604A, and S604T had no significant effect on the ability of MRP1 to confer resistance to any drug tested.
X
ABCC1 p.Ser604Ala 15260484:203:31
status: NEW216 In contrast, mutations N597A and S605A influenced only the drug resistance profile of MRP1, and mutation S604A affected the transport of only E217 G.
X
ABCC1 p.Ser604Ala 15260484:216:105
status: NEW270 In addition, although mutation S604T had no effect on any of the MRP1 functions tested, converting Ser604 to Ala decreased the apparent Km values and increased Vmax for E217 G uptake.
X
ABCC1 p.Ser604Ala 15260484:270:99
status: NEW
PMID: 17295059
[PubMed]
Chang XB et al: "A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1."
No.
Sentence
Comment
112
Many mutations in TM11, such as N590A, F594A, N597A, S604A and S605A, also modulate the drug resistance profile of MRP1 [79, 80].
X
ABCC1 p.Ser604Ala 17295059:112:53
status: NEW
PMID: 19949927
[PubMed]
Chang XB et al: "Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1."
No.
Sentence
Comment
104
Mutations of C43S in TM1 (112); P343A, K332L and K332D in TM6 (113, 114); W445A and P448A in TM8 (113, 115); T550A, T556A and P557A in TM10 (113, 116); N590A, F594A, P595A, N597A, S604A and S605A in TM11 (113, 117, 118); E1089Q, E1089A, E1089L, E1089N, K1092, S1097 and N1100 in TM14 (119, 120); R1197K in TM16 (121); Y1236F, T1241A, T1242A, T1242C, T1242S, T1242L, Y1243F, N1245A, W1246C, W1246A, W1246F, W1246Y or R1249K in TM17 (121-124) significantly affect MRP1 function.
X
ABCC1 p.Ser604Ala 19949927:104:180
status: NEW